Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 559

1.

The KdpD Sensor Kinase of Escherichia coli Responds to Several Distinct Signals To Turn on Expression of the Kdp Transport System.

Epstein W.

J Bacteriol. 2015 Sep 8;198(2):212-20. doi: 10.1128/JB.00602-15. Print 2016 Jan 15.

3.

When and how are spatial perceptions scaled?

Witt JK, Proffitt DR, Epstein W.

J Exp Psychol Hum Percept Perform. 2010 Oct;36(5):1153-60. doi: 10.1037/a0019947.

PMID:
20731519
4.

Pseudolymphoma evolving into diffuse large B-cell lymphoma.

Anandasabapathy N, Pulitzer M, Epstein W, Rosenman K, Latkowski JA.

Dermatol Online J. 2008 May 15;14(5):22.

PMID:
18627758
5.

The lighter side of deception research in the social sciences: social work as comedy.

Epstein WM.

J Infor Ethics. 2006 Spring;15(1):11-26. No abstract available.

PMID:
17061391
6.

Distances appear different on hills.

Stefanucci JK, Proffitt DR, Banton T, Epstein W.

Percept Psychophys. 2005 Aug;67(6):1052-60.

PMID:
16396013
7.

Tool use affects perceived distance, but only when you intend to use it.

Witt JK, Proffitt DR, Epstein W.

J Exp Psychol Hum Percept Perform. 2005 Oct;31(5):880-8.

PMID:
16262485
8.

Cutaneous sarcoidosis.

Epstein WL.

Semin Respir Crit Care Med. 2002 Dec;23(6):571-7.

PMID:
16088652
9.

Perceiving distance: a role of effort and intent.

Witt JK, Proffitt DR, Epstein W.

Perception. 2004;33(5):577-90.

PMID:
15250663
10.

Multiple paths for nonphysiological transport of K+ in Escherichia coli.

Buurman ET, McLaggan D, Naprstek J, Epstein W.

J Bacteriol. 2004 Jul;186(13):4238-45.

11.

The roles and regulation of potassium in bacteria.

Epstein W.

Prog Nucleic Acid Res Mol Biol. 2003;75:293-320. Review.

PMID:
14604015
12.

The role of effort in perceiving distance.

Proffitt DR, Stefanucci J, Banton T, Epstein W.

Psychol Sci. 2003 Mar;14(2):106-12.

PMID:
12661670
13.

The case against haste in the treatment of rheumatoid arthritis: comment on the editorial by Pincus et al.

Epstein WV.

Arthritis Rheum. 2003 Feb;48(2):573-5; author reply 576-9. No abstract available.

14.

Internalization: a metaphor we can live without.

Kubovy M, Epstein W.

Behav Brain Sci. 2001 Aug;24(4):618-25; discussion 652-791.

PMID:
12048945
15.

Analysis of the kefA2 mutation suggests that KefA is a cation-specific channel involved in osmotic adaptation in Escherichia coli.

McLaggan D, Jones MA, Gouesbet G, Levina N, Lindey S, Epstein W, Booth IR.

Mol Microbiol. 2002 Jan;43(2):521-36.

16.
17.

Modulation of KdpD phosphatase implicated in the physiological expression of the kdp ATPase of Escherichia coli.

Brandon L, Dorus S, Epstein W, Altendorf K, Jung K.

Mol Microbiol. 2000 Dec;38(5):1086-92.

18.
19.

Replacement of glycine 232 by aspartic acid in the KdpA subunit broadens the ion specificity of the K(+)-translocating KdpFABC complex.

Schrader M, Fendler K, Bamberg E, Gassel M, Epstein W, Altendorf K, Dröse S.

Biophys J. 2000 Aug;79(2):802-13.

20.

Treatment of severe atopic dermatitis by topical immune modulation using dinitrochlorobenzene.

Mills LB, Mordan LJ, Roth HL, Winger EE, Epstein WL.

J Am Acad Dermatol. 2000 Apr;42(4):687-9.

PMID:
10727322
21.

Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al.

Epstein WV.

Arthritis Rheum. 1999 Aug;42(8):1781-2. No abstract available. Erratum in: Arthritis Rheum 1999 Oct;42(10):2238.

22.

The Kdp-ATPase of Escherichia coli mediates an ATP-dependent, K+-independent electrogenic partial reaction.

Fendler K, Dröse S, Epstein W, Bamberg E, Altendorf K.

Biochemistry. 1999 Feb 9;38(6):1850-6.

PMID:
10026265
23.

Colorimetric determination of citrulline residues in proteins.

Sugawara K, Yoshizawa Y, Tzeng S, Epstein WL, Fukuyama K.

Anal Biochem. 1998 Dec 1;265(1):92-6.

PMID:
9866712
24.

Assembly of the Kdp complex, the multi-subunit K+-transport ATPase of Escherichia coli.

Gassel M, Siebers A, Epstein W, Altendorf K.

Biochim Biophys Acta. 1998 Dec 9;1415(1):77-84.

25.
26.

Thrombomodulin expression on dermal cells in normal and psoriatic skin.

Cuzzi-Maya T, Sidbury R, Epstein WL, Fukuyama K.

Arch Dermatol Res. 1998 May;290(5):233-9.

PMID:
9681673
27.
28.

Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein.

Epstein WV.

N Engl J Med. 1997 Nov 20;337(21):1559-60; author reply 1560-1. No abstract available.

PMID:
9380130
29.

Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.

Stricker RB, Goldberg B, Epstein WL.

Immunol Lett. 1997 Dec;59(3):145-50. Review.

PMID:
9419021
30.

Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease.

Stricker RB, Goldberg B, Mills LB, Epstein WL.

Res Virol. 1997 Sep-Oct;148(5):343-8.

PMID:
9403933
31.
32.

Silicone breast implants and breast feeding.

Epstein WA.

J Rheumatol. 1997 May;24(5):1013-4; author reply 1014-5. No abstract available.

PMID:
9150103
33.

Identification of the mouse calcium-binding proteins, MRP 8 and MRP 14, in Schistosoma mansoni-induced granulomas: biochemical and functional characterization.

Yang TH, Tzeng S, Cheng I, Burnett MG, Yoshizawa Y, Fukuyama K, Lee SC, Epstein WL.

J Leukoc Biol. 1997 Mar;61(3):258-66.

PMID:
9060448
34.

Two-dimensional crystals of the Kdp-ATPase of Escherichia coli.

Iwane AH, Ikeda I, Kimura Y, Fujiyoshi Y, Altendorf K, Epstein W.

FEBS Lett. 1996 Nov 4;396(2-3):172-6.

35.

Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience.

Epstein WV.

Arthritis Rheum. 1996 Nov;39(11):1773-80. Review. No abstract available.

PMID:
8912498
36.

Resorcinols and catechols: a clinical study of cross-sensitivity.

Knight TE, Boll P, Epstein WL, Prasad AK.

Am J Contact Dermat. 1996 Sep;7(3):138-45.

PMID:
8957327
37.

Silicone breast implants and sclerodermalike esophageal disease in breast fed infants.

Epstein WA.

JAMA. 1996 Jan 17;275(3):184-5. No abstract available.

PMID:
8604165
38.

Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.

Stricker RB, Goldberg B, Mills LB, Epstein WL.

J Am Acad Dermatol. 1995 Oct;33(4):608-11.

PMID:
7673493
39.

Immunological changes in patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene.

Stricker RB, Goldberg B, Epstein WL.

Lancet. 1995 Jun 10;345(8963):1505-6. No abstract available.

PMID:
7769913
40.

TrkH and its homolog, TrkG, determine the specificity and kinetics of cation transport by the Trk system of Escherichia coli.

Schlösser A, Meldorf M, Stumpe S, Bakker EP, Epstein W.

J Bacteriol. 1995 Apr;177(7):1908-10.

41.

Genetic evidence for two sequentially occupied K+ binding sites in the Kdp transport ATPase.

Buurman ET, Kim KT, Epstein W.

J Biol Chem. 1995 Mar 24;270(12):6678-85.

42.

Sclerodermalike esophageal disease in children of mothers with silicone breast implants.

Epstein WA.

JAMA. 1994 Sep 14;272(10):768; author reply 769-70. No abstract available.

PMID:
8078137
43.

Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene.

Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Henry J, Winger EE, Epstein WL.

J Am Acad Dermatol. 1994 Sep;31(3 Pt 1):462-6.

PMID:
8077474
44.

Occupational poison ivy and oak dermatitis.

Epstein WL.

Dermatol Clin. 1994 Jul;12(3):511-6. Review.

PMID:
7923948
45.

Thioprenols as hydrazinolysis products of prenylated proteins: dependence upon methylation of the prenylcysteine.

Leining LM, Epstein WW, Rilling HC.

Arch Biochem Biophys. 1994 Jun;311(2):199-204.

PMID:
8203881
46.

Efficacy of standard slow-acting antirheumatic drugs.

Epstein WV.

Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):32-8. Review.

PMID:
7939729
47.

Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation.

Handelman GJ, Epstein WL, Peerson J, Spiegelman D, Machlin LJ, Dratz EA.

Am J Clin Nutr. 1994 May;59(5):1025-32.

PMID:
8172086
48.

Interdependence of K+ and glutamate accumulation during osmotic adaptation of Escherichia coli.

McLaggan D, Naprstek J, Buurman ET, Epstein W.

J Biol Chem. 1994 Jan 21;269(3):1911-7.

49.

Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin.

Shindo Y, Witt E, Han D, Epstein W, Packer L.

J Invest Dermatol. 1994 Jan;102(1):122-4.

50.

Purification and characterization of NADPH-cytochrome P-450 reductase from rat epidermis.

Takahara H, Zaidi SI, Mukhtar H, Handa M, Epstein WL, Fukuyama K.

J Cell Biochem. 1993 Nov;53(3):206-12.

PMID:
8263037

Supplemental Content

Loading ...
Support Center